• No results found

Dinuclear Platinum Complexes as potential anticancer drugs : insights in the intracellular distribution

N/A
N/A
Protected

Academic year: 2021

Share "Dinuclear Platinum Complexes as potential anticancer drugs : insights in the intracellular distribution"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Dinuclear Platinum Complexes as potential anticancer drugs : insights

in the intracellular distribution

Kalayda, G.V.

Citation

Kalayda, G. V. (2006, February 1). Dinuclear Platinum Complexes as potential anticancer drugs : insights in the intracellular distribution. Retrieved from

https://hdl.handle.net/1887/4283

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4283

(2)

Propositions belonging to the thesis

Dinuclear platinum complexes as potential anticancer drugs: insights in the intracellular distribution

1. A number of cancer types exist, each having its own specific features. Drug behavior varies significantly between different cancers. This is the biggest challenge for cancer chemotherapy.

This thesis

2. Drug sequestration in lysosomes partly accounts for cisplatin resistance and cross-resistance in some tumors.

This thesis

3. Design of drug delivery systems based on platinum coordination compounds presents an alternative to the widely used covalent coupling of drugs to targeting proteins.

This thesis

4. Toxicity studies are as important as cytotoxicity tests in the evaluation of clinical usefulness of new potential drug candidates.

This thesis

5. In general, resistance is multifactorial, in that several mechanisms are encountered simultaneously within the same tumor cell. Thus, versatility of cisplatin resistance makes it so difficult to overcome.

Z. H. Siddik Oncogene 2003, 22, 7265. This thesis

6. Understanding the molecular profile of human tumors is essential to the effective use of cancer drugs.

B. A. Chabner, T. G. Roberts Jr Nature Rev. Cancer 2005, 5, 65

7. Further research should concentrate on various methods of platinum visualization in clinically obtained specimens as a predictive tool in cisplatin chemotherapy.

(3)

8. The accidental discovery of anti-proliferative properties of cisplatin by Rosenberg and co-workers shows that serendipity can save people’s lives. B. Rosenberg et al. Nature 1965, 205, 698

B. Rosenberg et al. Nature 1969, 222, 385

9. To beat cancer, science must develop faster than cancer does.

10. Choosing for fat-free products people often think they eat healthy and forget that fat is essential for normal growth and development of an organism.

11. Introducing a fast train service between Leiden and Utrecht would mean significant progress of the railway system in the Netherlands.

Referenties

GERELATEERDE DOCUMENTEN

No crystal structures of heterodinuclear ruthenium-platinum complexes, in which the two metal moieties are linked through a long and flexible linker, have been reported to date..

Thus, of the polynuclear trichlororuthenium and platinum terpyridyl complexes the tetranuclear complexes show the highest inhibition of cell growth at similar

The 33”, 44”, 55” and 66” protons of the trichlororuthenium(III) terpyridine complexes (including 1) display hyperfine shifts, which agree with their metal-proton distances, as

In conclusion, the research described in this Thesis has resulted in the synthesis of a class of polynuclear polypyridyl ruthenium and ruthenium-platinum complexes, for which

Omdat het in dit proefschrift gepresenteerde onderzoek zich heeft gericht op de synthese en evaluatie van polynucleaire rutheniumcomplexen en polynucleaire

Design and development of polynuclear ruthenium and platinum polypyridyl complexes in search of new anticancer agents.. Schilden, Karlijn

Dinuclear platinum complexes with fluorescent anthraquinones: cellular processing in A2780 human ovarian carcinoma cells.

is a strategy for labeling of nucleic acids and proteins based on cisplatin derivatives (so called ULS reagents). Schematic representation of a ULS reagent.. A leaving group can